Dashboard
Manage Tickers

AVNT AVIENT CORP

NYSE avient.com


$ 30.68 $ -0.30 (-0.97 %)    

Thursday, 06-Nov-2025 11:53:08 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.22 $ -10.57 (-1.7 %)
DIA $ 468.41 $ -3.62 (-0.77 %)
SPY $ 669.68 $ -6.79 (-1 %)
TLT $ 89.81 $ 0.25 (0.28 %)
GLD $ 366.07 $ -1.13 (-0.31 %)
$ 31.29
$ 31.08
$ 30.63 x 100
$ 30.72 x 8
$ 30.61 - $ 31.37
$ 27.44 - $ 53.20
1,752,461
na
2.87B
$ 1.41
$ 25.29
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-20-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 07-27-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 07-26-2022 06-30-2022 10-Q
15 04-27-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 07-30-2021 06-30-2021 10-Q
19 04-30-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-03-2020 09-30-2020 10-Q
22 07-22-2020 06-30-2020 10-Q
23 04-21-2020 03-31-2020 10-Q
24 02-19-2020 12-31-2019 10-K
25 10-22-2019 09-30-2019 10-Q
26 07-25-2019 06-30-2019 10-Q
27 04-17-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 10-24-2018 09-30-2018 10-Q
30 07-24-2018 06-30-2018 10-Q
31 04-26-2018 03-31-2018 10-Q
32 02-15-2018 12-31-2017 10-K
33 10-25-2017 09-30-2017 10-Q
34 07-25-2017 06-30-2017 10-Q
35 04-27-2017 03-31-2017 10-Q
36 02-16-2017 12-31-2016 10-K
37 10-26-2016 09-30-2016 10-Q
38 07-27-2016 06-30-2016 10-Q
39 04-26-2016 03-31-2016 10-Q
40 02-12-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

avient-affirms-fy2025-adj-eps-guidance-of-277-287-vs-280-est
Avient Affirms FY2025 Adj EPS Guidance of ...
11/05/2025 11:11:29

Avient (NYSE:AVNT) affirms FY2025 Adj EPS guidance from $2.77-$2.87 to $2.77-$2.87 vs $2.80 analyst estimate..

avient-q3-adj-eps-070-beats-069-estimate-sales-806500m-miss-824957m-estimate
Avient Q3 Adj. EPS $0.70 Beats $0.69 Estim...
11/05/2025 11:10:29

Avient (NYSE:AVNT) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.69 by 1.16 pe...

avient-increases-annual-dividend-from-108-to-110-per-share
Avient Increases Annual Dividend From $1.0...
10/08/2025 20:17:00

price-over-earnings-overview-avient
Price Over Earnings Overview: Avient
09/18/2025 16:02:03

this-protagonist-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Protagonist Therapeutics Analyst Begi...
09/17/2025 12:15:15

keybanc-initiates-coverage-on-avient-with-overweight-rating-announces-price-target-of-48
Keybanc Initiates Coverage On Avient with ...
09/17/2025 10:15:43

Keybanc analyst Aleksey Yefremov initiates coverage on Avient (NYSE:AVNT) with a Overweight rating and announces Price Targe...

Core News & Articles
A Congress Member Bought Up To $615K In La...
09/15/2025 15:00:21

baird-maintains-neutral-on-avient-lowers-price-target-to-37
Baird Maintains Neutral on Avient, Lowers ...
08/04/2025 11:47:03

Baird analyst Ben Kallo maintains Avient (NYSE:AVNT) with a Neutral and lowers the price target from $43 to $37.

avient-sees-q3-adj-eps-070-vs-068-est
Avient Sees Q3 Adj EPS $0.70 vs $0.68 Est
08/01/2025 10:15:35

Avient (NYSE:AVNT) is looking for Q3 Adj EPS of $0.70 vs $0.68 analyst estimate..

avient-narrows-fy2025-adj-eps-guidance-from-270-294-to-277-287-vs-278-est
Avient Narrows FY2025 Adj EPS Guidance fro...
08/01/2025 10:15:11

Avient (NYSE:AVNT) narrows FY2025 Adj EPS guidance from $2.70-$2.94 to $2.77-$2.87 vs $2.78 analyst estimate..

avient-q2-adj-eps-080-beats-079-estimate-sales-866500m-beat-853250m-estimate
Avient Q2 Adj. EPS $0.80 Beats $0.79 Estim...
08/01/2025 10:14:20

Avient (NYSE:AVNT) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.79 by 1.91 pe...

Core News & Articles
Earnings Scheduled For August 1, 2025
08/01/2025 08:32:17

whats-next-avients-earnings-preview
What's Next: Avient's Earnings Preview
07/31/2025 17:01:57

how-is-the-market-feeling-about-avient
How Is The Market Feeling About Avient?
07/10/2025 13:00:30

germany-has-become-the-worlds-largest-cannabis-importer-here-are-the-stocks-benefiting
Germany Has Become The World's Largest Can...
05/27/2025 18:24:58

Germany became the world's top importer of medical cannabis, but political pressure could challenge telehealth-driven growth.

avient-board-of-directors-appoints-ashish-k-khandpur-as-chairman-effective-may-14
Avient Board of Directors Appoints Ashish ...
05/14/2025 20:32:42

is-avient-gaining-or-losing-market-support
Is Avient Gaining or Losing Market Support?
05/12/2025 17:00:31

morgan-stanley-maintains-equal-weight-on-avient-lowers-price-target-to-41
Morgan Stanley Maintains Equal-Weight on A...
05/12/2025 14:50:24

Morgan Stanley analyst Angel Castillo maintains Avient (NYSE:AVNT) with a Equal-Weight and lowers the price target from $51 ...

what-analysts-are-saying-about-avient-stock
What Analysts Are Saying About Avient Stock
05/07/2025 18:01:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION